These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
479 related items for PubMed ID: 14990640
1. Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol. Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL. J Clin Oncol; 2004 Mar 01; 22(5):846-53. PubMed ID: 14990640 [Abstract] [Full Text] [Related]
2. Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach. Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL. Pediatr Blood Cancer; 2004 Aug 01; 43(2):126-33. PubMed ID: 15236278 [Abstract] [Full Text] [Related]
4. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors. Pico JL, Fadel E, Ibrahim A, Bourhis JH, Droz JP. Bull Cancer; 1995 Aug 01; 82 Suppl 1():56s-60s. PubMed ID: 7542945 [Abstract] [Full Text] [Related]
5. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J, Bosl GJ, Motzer RJ. J Clin Oncol; 2005 Sep 20; 23(27):6549-55. PubMed ID: 16170162 [Abstract] [Full Text] [Related]
6. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma. Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F. Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566 [Abstract] [Full Text] [Related]
7. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT. Obstet Gynecol; 1996 Apr 01; 87(4):527-31. PubMed ID: 8602303 [Abstract] [Full Text] [Related]
14. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery. Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA. Cancer J Sci Am; 1998 Apr 01; 4(2):110-24. PubMed ID: 9532413 [Abstract] [Full Text] [Related]
18. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group. J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987 [Abstract] [Full Text] [Related]
19. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy. Kumano M, Miyake H, Hara I, Muramaki M, Takenaka A, Fujisawa M. Hinyokika Kiyo; 2007 Dec 15; 53(12):851-6. PubMed ID: 18203521 [Abstract] [Full Text] [Related]
20. Malignant retroperitoneal and abdominal germ cell tumors: an intergroup study. Billmire D, Vinocur C, Rescorla F, Colombani P, Cushing B, Hawkins E, Davis M, London WB, Lauer S, Giller R, Children's Oncology Group. J Pediatr Surg; 2003 Mar 15; 38(3):315-8; discussion 315-8. PubMed ID: 12632341 [Abstract] [Full Text] [Related] Page: [Next] [New Search]